Etiqueta: clinical trials
-
The Effect of Umbilical Cord-derived Mesenchymal Stem Cell Transplantation in a Patient with Cerebral Palsy: A Case Report.
[fusion_builder_container hundred_percent=»no» hundred_percent_height=»no» hundred_percent_height_scroll=»no» hundred_percent_height_center_content=»yes» equal_height_columns=»no» menu_anchor=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» status=»published» publish_date=»» class=»» id=»» background_color=»» background_image=»» background_position=»center center» background_repeat=»no-repeat» fade=»no» background_parallax=»none» enable_mobile=»no» parallax_speed=»0.3″ video_mp4=»» video_webm=»» video_ogv=»» video_url=»» video_aspect_ratio=»16:9″ video_loop=»yes» video_mute=»yes» video_preview_image=»» border_size=»» border_color=»» border_style=»solid» margin_top=»» margin_bottom=»» padding_top=»» padding_right=»» padding_bottom=»» padding_left=»»][fusion_builder_row][fusion_builder_column type=»1_1″ layout=»1_1″ spacing=»» center_content=»no» link=»» target=»_self» min_height=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» class=»» id=»» background_color=»» background_image=»» background_image_id=»» background_position=»left top» background_repeat=»no-repeat» hover_type=»none»…
-
Multiple Sclerosis News Today: Stem Cell Institute MS Trial is #4 in Top 10 MS Stories of 2018
[fusion_builder_container hundred_percent=»no» hundred_percent_height=»no» hundred_percent_height_scroll=»no» hundred_percent_height_center_content=»yes» equal_height_columns=»no» menu_anchor=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» class=»» id=»» background_color=»» background_image=»» background_position=»center center» background_repeat=»no-repeat» fade=»no» background_parallax=»none» enable_mobile=»no» parallax_speed=»0.3″ video_mp4=»» video_webm=»» video_ogv=»» video_url=»» video_aspect_ratio=»16:9″ video_loop=»yes» video_mute=»yes» video_preview_image=»» border_size=»» border_color=»» border_style=»solid» margin_top=»» margin_bottom=»» padding_top=»» padding_right=»» padding_bottom=»» padding_left=»»][fusion_builder_row][fusion_builder_column type=»1_1″ layout=»1_1″ spacing=»» center_content=»no» link=»» target=»_self» min_height=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» class=»» id=»» background_color=»» background_image=»» background_position=»left top» background_repeat=»no-repeat» hover_type=»none» border_size=»0″ border_color=»» border_style=»solid»…
-
FDA DRAFT STEM CELL GUIDANCE DOCUMENTS EXPOSED AS IMPROPER RULEMAKING, BAD SCIENCE AND HEARTLESS PUBLIC POLICY
Go to Original Post on RickJaffe.com Today was a good day for people who want continued access stem cells outside of clinic trials, and also for people who want the FDA to allow faster access to this promising technology. There was a wide spectrum of opinions. Some stem cell companies involved in clinical trials wanted…
-
Why Stem Cells Work: Clinical Trials for Spinal Cord Injury, Multiple Sclerosis, Rheumatoid Arthritis, and Duchenne’s Muscular Dystrophy
—
por
en Bone Marrow Stem Cells, Clinical Trials, Duchenne’s muscular dystrophy, Duchenne’s muscular dystrophy, Medistem Labs Panama, Mesenchymal Stem Cells, Multiple Sclerosis, Muscular Dystrophy, muscular dystrophy, Neil Riordan PA PhD, News, Rheumatoid Arthritis, Spinal Cord Injury, Stem Cell Lecture Videos, Stem Cell Research, Stem Cell Therapy, umbilical cord tissue stem cellsNeil Riordan, PhD speaks at the Riordan-McKenna Institute and Stem Cell Institute fall seminar in Southlake, Texas on October 10, 2015. Dr. Riordan discusses: How our lab selects uses specialized screening techniques to select only the stem cells that we know will be the most useful for our patients. Only about 1 in 100 cords…
-
Clinical Trials for Multiple Sclerosis and Rheumatoid Arthritis using Umbilical Cord Tissue Mesenchymal Stem Cells
Stem Cell Institute and Medistem Panama founder, Neil Riordan, PhD discusses clinical trials for multiple sclerosis and rheumatoid arthritis using umbilical cord tissue-derived mesenchymal stem cells at our fall stem cell seminar in San Antonio. For more information about these trials and others, please visit www.translationalbiosciences.com. The multiple sclerosis trial is full but the RA…
-
After FDA Approval, Duchenne’s Muscular Dystrophy Patient Receives First Umbilical Cord Stem Cell Treatment in the United States
Ryan Benton, a 28 year-old Duchenne’s muscular dystrophy patient from Wichita, Kansas, received his first umbilical cord tissue-derived mesenchymal stem cell treatment yesterday at Asthma and Allergy Specialists of Wichita, KS following US FDA approval of his doctor’s application for a single patient, investigational new drug (IND) for compassionate use. Wichita, KS (PRWEB) September 10,…